Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1951 2
1952 2
1953 3
1954 2
1956 1
1957 4
1959 1
1964 1
1965 5
1966 8
1967 9
1968 11
1969 9
1970 12
1971 12
1972 11
1973 23
1974 13
1975 9
1976 5
1977 6
1978 6
1979 7
1980 4
1981 9
1982 9
1983 9
1984 10
1985 20
1986 16
1987 10
1988 11
1989 14
1990 8
1991 16
1992 19
1993 20
1994 19
1995 28
1996 31
1997 29
1998 19
1999 34
2000 33
2001 44
2002 41
2003 29
2004 42
2005 44
2006 54
2007 53
2008 70
2009 65
2010 74
2011 71
2012 94
2013 102
2014 134
2015 143
2016 106
2017 135
2018 146
2019 151
2020 135
2021 131
2022 155
2023 131
2024 48

Text availability

Article attribute

Article type

Publication date

Search Results

2,486 results

Results by year

Filters applied: . Clear all
Page 1
Bronchiectasis in children: diagnosis and treatment.
Chang AB, Bush A, Grimwood K. Chang AB, et al. Lancet. 2018 Sep 8;392(10150):866-879. doi: 10.1016/S0140-6736(18)31554-X. Lancet. 2018. PMID: 30215382 Free article. Review.
Bronchiectasis is conventionally defined as irreversible dilatation of the bronchial tree. ...Few randomised controlled trials provide high-level evidence for management strategies to treat the children affected by bronchiectasis. ...
Bronchiectasis is conventionally defined as irreversible dilatation of the bronchial tree. ...Few randomised controlled trials …
European Respiratory Society guidelines for the management of adult bronchiectasis.
Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, De Soyza A, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilaró J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD. Polverino E, et al. Eur Respir J. 2017 Sep 9;50(3):1700629. doi: 10.1183/13993003.00629-2017. Print 2017 Sep. Eur Respir J. 2017. PMID: 28889110 Free article.
There have been no previous international guidelines.The European Respiratory Society guidelines for the management of adult bronchiectasis describe the appropriate investigation and treatment strategies determined by a systematic review of the literature.A multidisciplina …
There have been no previous international guidelines.The European Respiratory Society guidelines for the management of adult bronchiectas …
Diagnosis and management of non-cystic fibrosis bronchiectasis.
Macfarlane L, Kumar K, Scoones T, Jones A, Loebinger MR, Lord R. Macfarlane L, et al. Clin Med (Lond). 2021 Nov;21(6):e571-e577. doi: 10.7861/clinmed.2021-0651. Clin Med (Lond). 2021. PMID: 34862215 Free PMC article. Review.
Bronchiectasis is a heterogeneous and increasingly prevalent chronic pulmonary disease that is associated with significant morbidity. In this review, we outline how patients with bronchiectasis may present clinically and describe an approach to its diagnosis, includ …
Bronchiectasis is a heterogeneous and increasingly prevalent chronic pulmonary disease that is associated with significant morbidity. …
Telerehabilitation for chronic respiratory disease.
Cox NS, Dal Corso S, Hansen H, McDonald CF, Hill CJ, Zanaboni P, Alison JA, O'Halloran P, Macdonald H, Holland AE. Cox NS, et al. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013040. doi: 10.1002/14651858.CD013040.pub2. Cochrane Database Syst Rev. 2021. PMID: 33511633 Free PMC article.
We checked reference lists of all included studies for additional references, and handsearched relevant respiratory journals and meeting abstracts. SELECTION CRITERIA: All randomised controlled trials and controlled clinical trials of telerehabilitation for the deli …
We checked reference lists of all included studies for additional references, and handsearched relevant respiratory journals and meeting abs …
Airway clearance techniques for bronchiectasis.
Lee AL, Burge AT, Holland AE. Lee AL, et al. Cochrane Database Syst Rev. 2015 Nov 23;2015(11):CD008351. doi: 10.1002/14651858.CD008351.pub3. Cochrane Database Syst Rev. 2015. PMID: 26591003 Free PMC article. Review.
BACKGROUND: People with non-cystic fibrosis bronchiectasis commonly experience chronic cough and sputum production, features that may be associated with progressive decline in clinical and functional status. ...The role of these techniques in acute exacerbation of …
BACKGROUND: People with non-cystic fibrosis bronchiectasis commonly experience chronic cough and sputum production, features that may …
Bronchiectasis: new therapies and new perspectives.
Chalmers JD, Chotirmall SH. Chalmers JD, et al. Lancet Respir Med. 2018 Sep;6(9):715-726. doi: 10.1016/S2213-2600(18)30053-5. Epub 2018 Feb 23. Lancet Respir Med. 2018. PMID: 29478908
We did a systematic review of scientific literature and clinical trial registries to identify agents in early-to-late clinical development for bronchiectasis in adults. In this Review, we discuss the mechanisms and potential roles of emerging therapies …
We did a systematic review of scientific literature and clinical trial registries to identify agents in early-to-late clini …
Endotypes in bronchiectasis: moving towards precision medicine. A narrative review.
Martins M, Keir HR, Chalmers JD. Martins M, et al. Pulmonology. 2023 Nov-Dec;29(6):505-517. doi: 10.1016/j.pulmoe.2023.03.004. Epub 2023 Apr 6. Pulmonology. 2023. PMID: 37030997 Free article. Review.
We searched PubMed and Google Scholar for randomized controlled trials (RCT), observational studies, systematic reviews and meta-analysis published from inception until October 2022, using the terms: "bronchiectasis", "endotypes", "biomarkers", "microbiome" and "inf …
We searched PubMed and Google Scholar for randomized controlled trials (RCT), observational studies, systematic reviews and meta-anal …
A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection.
Guan WJ, Xu JF, Luo H, Xu XX, Song YL, Ma WL, Liang ZA, Liu XD, Zhang GJ, Zhang XJ, Li RK, Zhu SY, Zhang YJ, Cai XJ, Wei LP, Tian DB, Zhao H, Chen PY, Qu JM, Zhong NS; TORNASOL Study Group. Guan WJ, et al. Chest. 2023 Jan;163(1):64-76. doi: 10.1016/j.chest.2022.07.007. Epub 2022 Jul 19. Chest. 2023. PMID: 35863486 Clinical Trial.
STUDY DESIGN AND METHODS: This was a phase 3, 16-week, multicenter, randomized, double-blind, placebo-controlled trial. Eligible adults with bronchiectasis were recruited from October 2018 to July 2021. ...INTERPRETATION: TIS is an effective treatment option …
STUDY DESIGN AND METHODS: This was a phase 3, 16-week, multicenter, randomized, double-blind, placebo-controlled trial. Eligib …
Inhaled antibiotics for lower airway infections.
Quon BS, Goss CH, Ramsey BW. Quon BS, et al. Ann Am Thorac Soc. 2014 Mar;11(3):425-34. doi: 10.1513/AnnalsATS.201311-395FR. Ann Am Thorac Soc. 2014. PMID: 24673698 Free PMC article. Review.
Food and Drug Administration and European Medicines Agency have approved their use in CF, they have not been approved in other disease areas due to lack of supportive clinical trial evidence. Injectable formulations of gentamicin, tobramycin, amikacin, ceftazidime, …
Food and Drug Administration and European Medicines Agency have approved their use in CF, they have not been approved in other disease areas …
Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study.
Shoemark A, Shteinberg M, De Soyza A, Haworth CS, Richardson H, Gao Y, Perea L, Dicker AJ, Goeminne PC, Cant E, Polverino E, Altenburg J, Keir HR, Loebinger MR, Blasi F, Welte T, Sibila O, Aliberti S, Chalmers JD. Shoemark A, et al. Am J Respir Crit Care Med. 2022 Apr 15;205(8):894-902. doi: 10.1164/rccm.202108-1889OC. Am J Respir Crit Care Med. 2022. PMID: 35050830
Objectives: To use multiple datasets available through the European Multicentre Bronchiectasis Audit and Research Collaboration to characterize eosinophilic bronchiectasis as a clinical entity focusing on the impact of eosinophils on bronchiectasis exa …
Objectives: To use multiple datasets available through the European Multicentre Bronchiectasis Audit and Research Collaboration to ch …
2,486 results